Back to Journals » Therapeutics and Clinical Risk Management » Volume 5

Review

Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myeloma

       
Total article views   HTML views PDF downloads Totals
32,093 Dovepress* 32,093+ 1,897 33,990
Totals 32,093 1,897 33,990
*Since 22 January 2009
+Since July 2016

View citations on Google Scholar